LAUREN BLISS: Open Payments
NPI 1396303954 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,404 in 100 payments from 35 companies in 2025. Trend: 2023 $126 · 2024 $1,117 · 2025 $2,404
Food & beverage: $2,404
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $227 |
| Novartis Pharmaceuticals Corporation | 9 | $186 |
| ABBVIE INC. | 8 | $178 |
| GlaxoSmithKline, LLC. | 6 | $164 |
| AstraZeneca Pharmaceuticals LP | 7 | $155 |
| Daiichi Sankyo Inc. | 4 | $99 |
| PFIZER INC. | 4 | $98 |
| Eisai Inc. | 4 | $95 |
| Astellas Pharma US Inc | 4 | $92 |
| SOBI, INC | 3 | $87 |
Products named: Enhertu, Epkinly, JEMPERLI, KISQALI, Lenvima, Vyloy, Vonjo, IMFINZI.
Industry payments across CO — which companies pay providers there.
